News
Public · Published
Viemed Healthcare Inc reports results for the quarter ended September 30 - Earnings Summary
Viemed Healthcare reported adjusted earnings of 11 cents per share for the quarter ended September 30, up from 9 cents a year earlier but below analysts' 13-cent average expectation. Revenue increased 12.2% to $80.67 million, slightly below the $80.78 million analysts expected; quarterly net income was $860,000.
Published:
Updated:
What happened
Viemed Healthcare reported adjusted earnings of 11 cents per share for the quarter ended September 30, up from 9 cents a year earlier but below analysts’ 13-cent average expectation. Revenue increased 12.2% to $80.67 million, slightly below the $80.78 million analysts expected; quarterly net income was $860,000.
Confirmed
Global impact / market context
Revenue growth indicates Viemed generated more sales than a year earlier, but earnings below analysts’ expectations show that growth did not fully translate into the profit per share investors had forecast. If the gap reflects higher costs, it could limit future profit growth unless sales gains offset them.
Analyst inference
The article reports that shares gained 27.3% so far this year, while analysts’ average rating was “buy” and their median 12-month price target was $12.50. Those figures suggest expectations were positive, making the earnings shortfall relevant to how investors judge whether growth supports those expectations.
Analyst inference
What to watch
- In the next results, compare revenue growth with adjusted earnings per share to see whether sales gains are translating into stronger profit for each share. Analyst inference
- Watch whether analyst earnings estimates change after this report; the article says estimates had fallen about 2.6% over three months and had no negative revisions in the last 30 days. Confirmed
- Look for company details on costs and the reasons earnings missed expectations, since the article gives no explanation and those factors could affect future profit growth. Analyst inference
Evidence
- Original source link unavailable